FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

675 letters match. Newest first.

  1. Natuzen Co., Ltd.

    Natuzen Co., Ltd. failed drug manufacturing rules for OTC products including Atoren Hand Sanitizer, with no methanol testing, cleaning validation, or quality unit.

    High risk
  2. Ogura Shokuhin Co. Ltd.

    Ogura Shokuhin’s dried fish products lacked a required seafood safety plan and had unsafe color and labeling violations.

    High risk
  3. Blue Caribbean Foods Inc.

    FDA warns Blue Caribbean Foods after inspection found its fresh tuna HACCP plan and records inadequate.

    High risk
  4. G.N.R. Group Co., LTD.

    FDA cited G.N.R. Group's frozen coconut juice safety plan for pasteurization too weak to control Clostridium botulinum.

    High risk
  5. Hacienda Mexican Foods, LLC

    FDA warns Hacienda Mexican Foods of Salmonella risk and missing controls in ready-to-eat tortillas.

    High risk
  6. Carbon Fire, LLC

    FDA told Carbon Fire its 213° Metabolism Boosting Complex is adulterated because N-Methyltyramine lacks a required safety notice.

    Medium
  7. Pingdingshan Tianjing Plant Albumen Co., Ltd.

    FDA cited Pingdingshan Tianjing Plant Albumen, a Chinese maker of ready-to-eat soy protein isolate, for insanitary conditions and unsupported test results on certificates.

    High risk
  8. Augustine Temperature Management, LLC

    FDA warns Augustine Temperature Management over patient warming devices after unreported burn and quality failures.

    High risk
  9. Korean Food, Inc.

    FDA inspected Korean Food, Inc.'s Texas sprout and kimchi facility and found Listeria monitoring gaps, insanitary conditions, and misbranded kimchi labels.

    High risk
  10. P.T. Sankei Medical Industries

    FDA warned P.T. Sankei Medical Industries over unapproved changes to its single-use sphygmomanometer and quality system violations.

    High risk
  11. Future Diagnostics Solutions B.V.

    FDA cites Future Diagnostics over quality-system and reporting failures for STAT IntraOperative Intact PTH immunoassay kits.

    High risk
  12. C&T Dream Co., Ltd.

    C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.

    High risk
  13. Natco Pharma Limited

    FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.

    High risk
  14. Master Paints & Chemicals Corp.

    FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.

    High risk
  15. Soulaire Corporation

    FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.

    High risk
  16. Euro USA Inc

    Euro USA Inc’s seafood HACCP plans had inadequate temperature limits, monitoring, and corrective actions.

    High risk
  17. Appleton City Feed Service LLC

    FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.

    High risk
  18. Jiangsu Meifan Biotechnology Co. Ltd.

    FDA cites Jiangsu Meifan Biotechnology for OTC drug manufacturing-rule failures and import alert.

    High risk
  19. Antaria Pty. Ltd.

    FDA warned Antaria Pty. Ltd. about manufacturing quality failures in its active drug ingredient, including poor out-of-specification investigations and testing.

    High risk
  20. Agena Bioscience, Inc.

    Agena Bioscience marketed its iPLEX HS Colon Panel with the MassARRAY4 System for clinical diagnosis without FDA clearance or approval.

    High risk
  21. Betone S.A. de C.V.

    FDA warns Betone S.A. de C.V. over manufacturing violations for OTC antiseptic wipes, including subpotent active and missing glycerin safety tests.

    High risk
  22. Beckman Coulter Inc.

    FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.

    High risk
  23. Zoet Poultry, Inc.

    Zoet Poultry's shell egg farm lacked an implemented Salmonella Enteritidis prevention plan and required environmental testing.

    High risk
  24. Regal Health Food International, Inc.

    Regal Health Food International recalled milk chocolate raisins packed with peanuts but labeled without a peanut allergen declaration.

    High risk
  25. New York State Psychiatric Institute IRB

    FDA warned New York State Psychiatric Institute's review board it failed to report serious research problems and reviewed drug studies without required nonscientific member.

    High risk
  26. Higley Industries, Inc.

    FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.

    High risk
  27. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  28. Jiangsu Shenli Medical Production Co., Ltd.

    FDA says Jiangsu Shenli marketed many piston syringes in the U.S. without required clearance or approval.

    High risk
  29. Sol-Millennium Medical, Inc.

    Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.

    High risk
  30. Furst-McNess Company

    Furst-McNess's Lodi, Wisconsin feed mill made goat feed with toxic levels of monensin, sickening and killing goats.

    High risk
  31. Thai Nakorn Patana Co., Ltd.

    FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.

    High risk
  32. Bell International Laboratories, Inc.

    Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.

    High risk
  33. Barsotti Juice Company, Inc.

    FDA warned Barsotti Juice that its organic carrot juice safety plan does not control Clostridium botulinum.

    High risk
  34. Knickerbocker 365, Inc.

    Knickerbocker 365 recalled hamburger buns that contained undeclared milk, and FDA found no allergen labeling controls at packaging.

    High risk
  35. Colgin, Inc.

    FDA warned Colgin that its OTC drug ChigaRid External Analgesic violated manufacturing quality rules, including expired ingredients and missing tests.

    High risk
  36. Trang Thuy Seafood Co., LTD

    FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.

    High risk
  37. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  38. Empacadora Bilbo S.A. DBA Bilbosa

    FDA warns Ecuadorian seafood processor Bilbosa over seafood safety plan gaps for histamine and C. botulinum.

    High risk
  39. Sichuan Deebio Pharmaceutical Co. Ltd.

    FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.

    High risk
  40. Pt Dua Kelinci

    FDA found Pt Dua Kelinci made ready-to-eat snacks under insanitary conditions, with dirty equipment and allergen cross-contact risks.

    High risk
  41. US Chem Labs

    FDA warned US Chem Labs that it sells unapproved and misbranded Semaglutide, Tirzepatide, and Thymalin drugs online.

    High risk
  42. Synthetix Inc. DBA Helix Chemical Supply

    FDA says Synthetix Inc., doing business as Helix Chemical Supply, sold unapproved and misbranded Semaglutide and Tirzepatide drugs online.

    High risk
  43. Ningbo Poplar Daily-Use

    FDA warned Ningbo Poplar Daily-Use that its OTC drugs had manufacturing quality failures in testing, component identity checks, and stability data.

    High risk
  44. Madhu Instruments Private Limited

    FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.

    High risk
  45. Iowa Egg Company Inc.

    Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.

    High risk
  46. Indian Groceries and Spices, Inc.

    FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.

    Medium
  47. Ehy Holdings, LLC

    FDA warned Ehy Holdings over unupdated drug listings for nicotine patches and creams, calling products misbranded.

    Low
  48. Inmar Supply Chain Solutions, LLC

    FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.

    High risk
  49. Nantong Furuida Packaging Products Co., Ltd.

    Nantong Furuida, an over-the-counter drug manufacturer, failed required manufacturing controls and methanol checks, leading to an FDA import alert.

    High risk
  50. Glicerinas Industriales, S.A. de C.V.

    FDA warned Glicerinas Industriales over CGMP failures in repackaged glycerin and propylene glycol, including DEG/EG testing and particulate contamination.

    High risk